296 related articles for article (PubMed ID: 17722182)
1. About audience-specific communication.
Burlon O
Biotechnol J; 2007 Sep; 2(9):1070-1. PubMed ID: 17722182
[No Abstract] [Full Text] [Related]
2. Synthetic biology through the prism of scenarios.
Rutz B
Biotechnol J; 2007 Sep; 2(9):1072-5. PubMed ID: 17703494
[No Abstract] [Full Text] [Related]
3. Talking biotech with the public.
Brauerhoch FO; Ewen C; Sinemus K
Biotechnol J; 2007 Sep; 2(9):1076-80. PubMed ID: 17703483
[TBL] [Abstract][Full Text] [Related]
4. Bringing scientists to the people--the Co-Extra website.
Breyer D; Daubresse P; Sneyers M
Biotechnol J; 2007 Sep; 2(9):1081-5. PubMed ID: 17703490
[TBL] [Abstract][Full Text] [Related]
5. The difficulty of structuring and focusing the co-existence debate in Europe.
Custers R
Biotechnol J; 2007 Sep; 2(9):1086-7. PubMed ID: 17703493
[TBL] [Abstract][Full Text] [Related]
6. Talking with the public--challenging the public scare.
Sinemus K
Biotechnol J; 2007 Sep; 2(9):1047. PubMed ID: 17768765
[No Abstract] [Full Text] [Related]
7. Portals, blogs and co.: the role of the Internet as a medium of science communication.
Minol K; Spelsberg G; Schulte E; Morris N
Biotechnol J; 2007 Sep; 2(9):1129-40. PubMed ID: 17703484
[TBL] [Abstract][Full Text] [Related]
8. Future societal issues in industrial biotechnology.
Schuurbiers D; Osseweijer P; Kinderlerer J
Biotechnol J; 2007 Sep; 2(9):1112-20. PubMed ID: 17639531
[TBL] [Abstract][Full Text] [Related]
9. Communication of gene technology--a difficult enterprise: a journalist's view on biotech communication.
Spahl T; Deichmann T
Biotechnol J; 2007 Sep; 2(9):1064-6. PubMed ID: 17768770
[No Abstract] [Full Text] [Related]
10. Transparent communication strategy on GMOs: will it change public opinion?
Sinemus K; Egelhofer M
Biotechnol J; 2007 Sep; 2(9):1141-6. PubMed ID: 17703492
[TBL] [Abstract][Full Text] [Related]
11. Get up, stand up: stand up for your rights!--Private thoughts of a citizen.
Katzek JA
Biotechnol J; 2007 Sep; 2(9):1067-9. PubMed ID: 17722181
[No Abstract] [Full Text] [Related]
12. Options for a rational dialogue on the acceptance of biotechnology.
von Grebmer K; Omamo SW
Biotechnol J; 2007 Sep; 2(9):1121-8. PubMed ID: 17703485
[TBL] [Abstract][Full Text] [Related]
13. Public perceptions of biotechnology.
McHughen A
Biotechnol J; 2007 Sep; 2(9):1105-11. PubMed ID: 17639530
[TBL] [Abstract][Full Text] [Related]
14. Perspective: Why communication in biotechnology is important.
Gassen HG
Biotechnol J; 2007 Sep; 2(9):1051-2. PubMed ID: 17768767
[No Abstract] [Full Text] [Related]
15. Biotechnology: the language of multiple views in Māori communities.
Te Momo OH
Biotechnol J; 2007 Sep; 2(9):1179-83. PubMed ID: 17703491
[TBL] [Abstract][Full Text] [Related]
16. [Genome square: will direct conversations between scientists and the public become a new method for the communication of science in the society?].
Kato K
Tanpakushitsu Kakusan Koso; 2005 Dec; 50(16 Suppl):2302-7. PubMed ID: 16411466
[No Abstract] [Full Text] [Related]
17. Biotechnology and the popular press: hype and the selling of science.
Caulfield T
Trends Biotechnol; 2004 Jul; 22(7):337-9. PubMed ID: 15245905
[TBL] [Abstract][Full Text] [Related]
18. Improving biotechnology communication.
Weitze MD; Pühler A;
Biotechnol J; 2013 Sep; 8(9):970-2. PubMed ID: 23801558
[TBL] [Abstract][Full Text] [Related]
19. Assets for mastering media relations.
Steinerman P
Nat Biotechnol; 2003 Jul; 21 Suppl():BE59-61. PubMed ID: 12874984
[No Abstract] [Full Text] [Related]
20. Talking to the public about a pandemic: some applications of the WHO outbreak communication guidelines.
Lanard J
Yale J Biol Med; 2005 Oct; 78(5):373-80. PubMed ID: 17132344
[No Abstract] [Full Text] [Related]
[Next] [New Search]
